tradingkey.logo
tradingkey.logo
Suchen

Elevance Health Inc

ELV
Zur Watchlist hinzufügen
408.235USD
-9.655-2.31%
Handelsschluss 07/06, 16:00ETKurse um 15 Minuten verzögert
90.11BMarktkapitalisierung
17.25KGV TTM

mehr Informationen über Elevance Health Inc Unternehmen

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Elevance Health Inc Informationen

BörsenkürzelELV
Name des UnternehmensElevance Health Inc
IPO-datumOct 30, 2001
CEOBoudreaux (Gail K)
Anzahl der mitarbeiter103158
WertpapierartOrdinary Share
GeschäftsjahresendeOct 30
Addresse220 Virginia Avenue
StadtINDIANAPOLIS
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl46204
Telefon18003311476
Websitehttps://www.elevancehealth.com/
BörsenkürzelELV
IPO-datumOct 30, 2001
CEOBoudreaux (Gail K)

Führungskräfte von Elevance Health Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.91K
+5.68%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
5.49K
+10.26%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
5.35K
+10.52%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.55K
-10.40%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
2.21K
+25.49%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Lewis (Lew) Hay, III
Mr. Lewis (Lew) Hay, III
Independent Director
Independent Director
--
--
Mr. Peter D. (Pete) Haytaian
Mr. Peter D. (Pete) Haytaian
Executive Vice President and President, Carelon and CarelonRx
Executive Vice President and President, Carelon and CarelonRx
--
--
Mr. R. Kerry Clark
Mr. R. Kerry Clark
Independent Director
Independent Director
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.91K
+5.68%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
5.49K
+10.26%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
5.35K
+10.52%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.55K
-10.40%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
2.21K
+25.49%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Elevance Health Inc?

Die fünf größten Anteilseigner von Elevance Health Inc sind: Mr. Ramiro G. Peru

Wie viele Institutionen halten Anteile an Elevance Health Inc (ELV)?

Mit Stand vom 2026Q1 halten 3164 Institutionen Anteile an Elevance Health Inc, mit einem Gesamtmarktwert von etwa 206.68M, was 95.17% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -8943966.00 gestiegen.